Written Evidence: NHS Science and Technology Committee's Inquiry on Genomics and Genome Editing
By Center for Genetics and Society,
National Health Service
| 10. 24. 2017
- Thank you for the opportunity to contribute evidence toward your investigation of genomics and genome editing in the NHS.
- The Center for Genetics and Society is a public-interest non-governmental organization working to encourage responsible uses and effective societal governance of human genetic and reproductive technologies and other emerging technologies. We work with a vibrant international network of scientists, health professionals, civil society leaders, and others. The Center supports benign and beneficent medical applications of these technologies, and opposes those applications that objectify and commodify human life and threaten to divide human society.
- In response to The Committee’s invitation for written evidence on the recommendations made by the Chief Medical Officer in ‘Generation Genome,’ and in keeping with our organizational mission, our comments focus on the importance of maintaining the existing prohibition on germline genome editing for reproduction or clinical applications, even as the NHS moves to integrate genomic medicine and somatic gene therapies. We also address some of the future lines of inquiry included in the previous committee’s report.
- Here we summarize the points that follow:
- The UK should maintain a ban on human germline editing for reproduction...
Related Articles
By Nick Paul Taylor, BioSpace | 03.14.2024
A U.K. watchdog balked at the cost-effectiveness of Vertex Pharmaceuticals’ CRISPR-based sickle cell disease therapy Thursday, recommending against funding the treatment unless uncertainties can be cleared up satisfactorily.
The U.K. became the first country to authorize Vertex’s Casgevy (exagamglogene...
By Anna Collinson, Maryam Ahmed and Bella McShane, BBC | 03.12.2024
Women who freeze their eggs are being misled by some UK clinics about their chances of having a baby, a fertility charity says.
The Fertility Network was reacting to BBC analysis that found 41% of clinics offering the service privately...
By Isabelle Bartram, Guest Contributor
| 03.13.2024
Note: This article was originally published in February 2024 in issue 268 of the German-language journal Der Gen-ethische Informationsdienst (GID). It is also part of an English-language dossier on Heritable Human Genome Editing published at the same time. Minor edits have been made.
Calls for German embryo research
Pressure on the German Embryo Protection Act is growing. The scientific community is launching a renewed attack on the controversial law and demands access to embryos for so-called high-ranking research objectives. "Germline therapies" are...
By Andrew Joseph, STAT | 02.22.2024
In the years leading up to Russia’s invasion, Ukraine had become a burgeoning hub of clinical trials, particularly in oncology. The war put a hold on the vast majority of those studies.
But as the country marks two years this...